All terms in HP
| Label | Id | Description |
|---|---|---|
| Limitation of neck motion | HP_0005986 | |
| Neck muscle weakness | HP_0000467 | [Decreased strength of the neck musculature.] |
| Abnormal morphology of the musculature of the neck | HP_0011006 | [An abnormality of the neck musculature.] |
| Increased adipose tissue around the neck | HP_0000468 | [An increased amount of subcutaneous fat tissue around the neck.] |
| Sacroiliac joint synovitis | HP_0012449 | [Inflammation of the synovial membrane of the sacroiliac joint.] |
| Narrow nose | HP_0000460 | [Interalar distance more than 2 SD below the mean for age, or alternatively, an apparently decreased width of the nasal base and alae.] |
| Delayed myelination | HP_0012448 | [Delayed myelination.] |
| Abnormal myelination | HP_0012447 | [Any anomaly in the process by which myelin sheaths are formed and maintained around neurons.] |
| Gallbladder dyskinesia | HP_0012442 | [Reduced motility of the gallbladder with reduced emptying fraction.] |
| Sphincter of Oddi dyskinesia | HP_0012441 | [Reduced motility through the sphincter of Oddi, resulting in impedance of bile and pancreatic juice flow from the common bile duct into the duodenum.] |
| Low CSF 5-methyltetrahydrofolate | HP_0012446 | [A reduced concentration of 5-methyltetrahydrofolate(2-) in the cerebrospinal fluid (CSF). 5-methyltetrahydrofolate is the active folate metabolite.] |
| Brain atrophy | HP_0012444 | [Partial or complete wasting (loss) of brain tissue that was once present.] |
| obsolete Brain very small | HP_0001322 | |
| heterocycle metabolic process | GO_0046483 | [The chemical reactions and pathways involving heterocyclic compounds, those with a cyclic molecular structure and at least two different atoms in the ring (or rings).] |
| Cystic hygroma | HP_0000476 | [A cystic lymphatic lesion of the neck.] |
| Long neck | HP_0000472 | [Increased inferior-superior length of the neck.] |
| Thickened nuchal skin fold | HP_0000474 | [A thickening of the skin thickness in the posterior aspect of the fetal neck. A nuchal fold measurement is obtained in a transverse section of the fetal head at the level of the cavum septum pellucidum and thalami, angled posteriorly to include the cerebellum. The measurement is taken from the outer edge of the occiput bone to the outer skin limit directly in the midline. A measurement 6 mm or more is considered significant between 18 and 24 weeks and a measurement of 5 mm or more is considered significant at 16 to 18 weeks (PMID:16100637).] |
| Fetal ultrasound soft marker | HP_0011425 | [An finding upon obstetric ultrasound examination performed at around 16 to 20 weeks of gestation that is abnormal but not clearly identifiable as a fetal anatomic malformation or growth restriction. Such findings are known as soft markers since they are associated with increased risk for fetal aneuploidy or other disorders.] |
| Broad neck | HP_0000475 | [Increased side-to-side width of the neck.] |
| Short neck | HP_0000470 | [Diminished length of the neck.] |